Original Research

Published on 04 Nov 2022

A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer

in Molecular and Cellular Oncology

Ling Li
Bao-jia Zou
Juan-zhi Zhao
Jia-bi Liang
Zi-yue She
Wen-ying Zhou
Si-xiao Lin
Lin Tian
Wen-ji Luo
Fa-zhong He

Frontiers in Oncology

doi 10.3389/fonc.2022.961274

3,268 views
5 citations

Original Research

Published on 03 Nov 2022

DJ-1 promotes osteosarcoma progression through activating CDK4/RB/E2F1 signaling pathway

in Molecular and Cellular Oncology

Zhitao Han
Lining Wang
Dongshuo Wang
Luosheng Zhang
Yifeng Bi
Xinlei Zheng
Weibo Liu
Guangjian Bai
Zhenhua Wang
Wei Wan

Frontiers in Oncology

doi 10.3389/fonc.2022.1036401

2,008 views
3 citations

Original Research

Published on 03 Nov 2022

Prediction of the immunological and prognostic value of five signatures related to fatty acid metabolism in patients with cervical cancer

in Molecular and Cellular Oncology

Qiongjing Zeng
Huici Jiang
Fang Lu
Mingxu Fu
Yingying Bi
Zengding Zhou
Jiajing Cheng
Jinlong Qin

Frontiers in Oncology

doi 10.3389/fonc.2022.1003222

2,159 views
2 citations

Original Research

Published on 03 Nov 2022

Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma

in Molecular and Cellular Oncology

Shuguang Zhou
Weiyu Zhang
Wujun Cao
Qinqin Jin
Xiya Jiang
Xiaomin Jiang
Yinting Yang
Hui Yao
Guo Chen
Wei Gao

Frontiers in Oncology

doi 10.3389/fonc.2022.1049773

1,799 views
2 citations

Systematic Review

Published on 03 Nov 2022

ER stress as a trigger of UPR and ER-phagy in cancer growth and spread

in Molecular and Cellular Oncology

Alessandro Cherubini
Ester Zito

Frontiers in Oncology

doi 10.3389/fonc.2022.997235

5,001 views
8 citations

Original Research

Published on 02 Nov 2022

Functional analysis of the short splicing variant encoded by CHI3L1/YKL-40 in glioblastoma

in Molecular and Cellular Oncology

Mengqi Shi
Qianyun Ge
Xinrong Wang
Wenbin Diao
Ben Yang
Sipeng Sun
Guohui Wang
Tian Liu
Andrew Man-Lok Chan
Zhiqin Gao

Frontiers in Oncology

doi 10.3389/fonc.2022.910728

3,003 views
2 citations

Original Research

Published on 02 Nov 2022

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis

in Molecular and Cellular Oncology

Xinqiang Li
Peng Jiang
Ruixia Li
Bin Wu
Kai Zhao
Shipeng Li
Jinzhen Cai

Frontiers in Oncology

doi 10.3389/fonc.2022.1009036

4,715 views
8 citations

Original Research

Published on 02 Nov 2022

Deep learning-based transcriptome model predicts survival of T-cell acute lymphoblastic leukemia

in Molecular and Cellular Oncology

Lenghe Zhang
Lijuan Zhou
Yulian Wang
Chao Li
Pengjun Liao
Liye Zhong
Suxia Geng
Peilong Lai
Xin Du
Jianyu Weng

Frontiers in Oncology

doi 10.3389/fonc.2022.1057153

1,875 views
1 citation

Original Research

Published on 01 Nov 2022

The involvement of high succinylation modification in the development of prostate cancer

in Molecular and Cellular Oncology

Zhenyang Zhang
Yanru Chen
Lingyu Fang
Jiang Zhao
Shishan Deng

Frontiers in Oncology

doi 10.3389/fonc.2022.1034605

2,628 views
9 citations

Review

Published on 31 Oct 2022

Noncoding RNA-mediated regulation of pyroptotic cell death in cancer

in Molecular and Cellular Oncology

Man Wang
Yuan Zhang
Wenguang Chang
Lei Zhang
Konstantinos N. Syrigos
Peifeng Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1015587

2,257 views
13 citations

Original Research

Published on 31 Oct 2022

Consequences of somatic mutations of GIRK1 detected in primary malign tumors on expression and function of G-protein activated, inwardly rectifying, K+ channels

in Molecular and Cellular Oncology

Brigitte Pelzmann
Ahmed Hatab
Susanne Scheruebel
Sonja Langthaler
Theresa Rienmueller
Armin Sokolowski
Astrid Gorischek
Dieter Platzer
Klaus Zorn-Pauly
Stephan W. Jahn

Frontiers in Oncology

doi 10.3389/fonc.2022.998907

1,542 views

Case Report

Published on 31 Oct 2022

Case report: A novel reciprocal ROS1-CD74 fusion in a NSCLC patient partially benefited from sequential tyrosine kinase inhibitors treatment

in Molecular and Cellular Oncology

Xugang Zhang
Baoming Wang
Chunyang Wang
Chengde Liao
Shiping Wang
Ran Cao
Tonghui Ma
Kun Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1021342

2,870 views
5 citations

Correction

Published on 31 Oct 2022

Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue

in Molecular and Cellular Oncology

Rossella Loria
Patrizia Vici
Francesca Sofia Di Lisa
Silvia Soddu
Marcello Maugeri-Saccà
Giulia Bon

Frontiers in Oncology

doi 10.3389/fonc.2022.1063651

721 views

Original Research

Published on 31 Oct 2022

A new acidic microenvironment related lncRNA signature predicts the prognosis of liver cancer patients

in Molecular and Cellular Oncology

Peng Jiang
Wenbo Xue
Cheng Xi
Lin Zhuang
Zhiping Yuan
Zhilin Liu
Tao Sun
Xuezhong Xu
Yulin Tan
Wei Ding

Frontiers in Oncology

doi 10.3389/fonc.2022.1016721

2,232 views
22 citations

Original Research

Published on 31 Oct 2022

Plasma exosomal tRNA‐derived fragments as diagnostic biomarkers in non-small cell lung cancer

in Molecular and Cellular Oncology

Baibing Zheng
Xingguo Song
Li Wang
Yue Zhang
Youyong Tang
Shiwen Wang
Lei Li
Yawen Wu
Xianrang Song
Li Xie

Frontiers in Oncology

doi 10.3389/fonc.2022.1037523

2,467 views
19 citations

Case Report

Published on 31 Oct 2022

Case Report: A patient with the rare third-generation TKI-resistant mutation EGFR L718Q who responded to afatinib plus cetuximab combination therapy

in Molecular and Cellular Oncology

Guoqing Zhang
Beibei Yan
Yanan Guo
Hang Yang
Xiangnan Li
Jindong Li

Frontiers in Oncology

doi 10.3389/fonc.2022.995624

2,466 views
5 citations

Navigation group

Articles

A novel DNA damage repair-related signature for predicting prognositc and treatment response in non-small lung cancer

DJ-1 promotes osteosarcoma progression through activating CDK4/RB/E2F1 signaling pathway

Prediction of the immunological and prognostic value of five signatures related to fatty acid metabolism in patients with cervical cancer

Development and validation of an autophagy-related long non-coding RNA prognostic signature for cervical squamous cell carcinoma and endocervical adenocarcinoma

ER stress as a trigger of UPR and ER-phagy in cancer growth and spread

Functional analysis of the short splicing variant encoded by CHI3L1/YKL-40 in glioblastoma

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis

Deep learning-based transcriptome model predicts survival of T-cell acute lymphoblastic leukemia

The involvement of high succinylation modification in the development of prostate cancer

Noncoding RNA-mediated regulation of pyroptotic cell death in cancer

Consequences of somatic mutations of GIRK1 detected in primary malign tumors on expression and function of G-protein activated, inwardly rectifying, K+ channels

Case report: A novel reciprocal ROS1-CD74 fusion in a NSCLC patient partially benefited from sequential tyrosine kinase inhibitors treatment

Corrigendum: Cross-resistance among sequential cancer therapeutics: An emerging issue

A new acidic microenvironment related lncRNA signature predicts the prognosis of liver cancer patients

Plasma exosomal tRNA‐derived fragments as diagnostic biomarkers in non-small cell lung cancer

Case Report: A patient with the rare third-generation TKI-resistant mutation EGFR L718Q who responded to afatinib plus cetuximab combination therapy